IPSC Century Therapeutics, Inc.
Healthcare$2.17-3.98%ClosedMarket Cap: $187.9M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
0
Dispositions
2
Buy/Sell Ratio
0.00
Net Shares
-1,629
Shares Acquired
0
Shares Disposed
1,629
Total Bought ($)
$0.00
Total Sold ($)
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 31,172 | $2.34 | 3,679,786 |
| Wed May 06 | Carr Douglas | officer: SVP Finance & Operations | Sell | 264 | $2.34 | 506,997 |
| Fri Apr 10 | Murphy Martin Patrick | director | Sell | 88,000 | $0.59 | 88,000 |
| Fri Apr 10 | Murphy Martin Patrick | Sell | 0 | $0.00 | 0 | |
| Fri Apr 03 | Cowan Chad | officer: Chief Scientific Officer | Sell | 1,365 | $2.19 | 1,175,680 |
| Mon Mar 16 | Russotti Gregory | officer: See Remarks | Sell | 10,076 | $2.55 | 515,427 |
| Mon Mar 16 | Carr Douglas | officer: SVP Finance & Operations | Sell | 7,043 | $2.55 | 507,261 |
| Fri Mar 13 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 55,397 | $2.73 | 3,710,958 |
| Fri Mar 13 | Cowan Chad | officer: Chief Scientific Officer | Sell | 1,431 | $2.73 | 1,177,045 |
| Wed Mar 11 | Russotti Gregory | officer: See Remarks | Sell | 479 | $2.54 | 525,503 |
| Tue Mar 10 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 463 | $2.56 | 3,766,355 |
| Wed Feb 18 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 31,172 | $1.75 | 3,766,818 |
| Thu Feb 05 | Carr Douglas | officer: SVP Finance & Operations | Sell | 323 | $1.82 | 514,551 |
| Wed Feb 04 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 945,000 | $1.84 | 945,000 |
| Wed Feb 04 | Pfeiffenberger Brent | director, officer: President and CEO | Sell | 475,000 | $0.00 | 3,797,990 |